Effect of video conferencing between primary and secondary care specialists on type 2 diabetes medication

IF 12.4 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
Thim Prætorius, Anne Sofie Baymler Lundberg, Eskild Klausen Fredslund, Niklas Blach Rossen, Søren Gregersen, Anders Prior, Esben Søndergaard, Søren Tang Knudsen, Annelli Sandbæk
{"title":"Effect of video conferencing between primary and secondary care specialists on type 2 diabetes medication","authors":"Thim Prætorius, Anne Sofie Baymler Lundberg, Eskild Klausen Fredslund, Niklas Blach Rossen, Søren Gregersen, Anders Prior, Esben Søndergaard, Søren Tang Knudsen, Annelli Sandbæk","doi":"10.1038/s41746-025-01570-w","DOIUrl":null,"url":null,"abstract":"<p>Although promising, the clinical impact of video conferencing between primary and secondary care specialists lacks trial evidence. We conducted a two-arm RCT (clinicaltrials.gov: NCT05268081) to evaluate whether four video conferences over 12 months between endocrinologists and general practitioners improved medication for people with type 2 diabetes (T2D). Twenty-seven of 100 general practices in Aarhus, Denmark were matched and randomized. Primary outcomes: the proportion of people with T2D and 1) ischemic heart disease treated with glucagon-like peptide 1 receptor agonist (GLP1-RA) and/or sodium glucose cotransporter 2 inhibitor (SGLT2I), 2) micro/macro-albuminuria treated with angiotensin-converting-enzyme-inhibitor (ACE) or angiotensin-2-receptorantagonist (AT2), 3) low-density lipoprotein &gt;2.5 mmol/L treated with statins. Results showed a 17.6% difference [95% CI 4.6%; 30.7%] in GLP1-RA/SGLT2I prescriptions and minimal differences for ACE/AT2 (−1.1% [95% CI −2.8%; 0.6%]) and statins (0.0% [95% CI −3.5%; 3.6%]), attributed to a ceiling effect. Video conferencing can help bridge treatment gaps, particularly for recently updated guidelines.</p>","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":"72 1","pages":""},"PeriodicalIF":12.4000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41746-025-01570-w","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Although promising, the clinical impact of video conferencing between primary and secondary care specialists lacks trial evidence. We conducted a two-arm RCT (clinicaltrials.gov: NCT05268081) to evaluate whether four video conferences over 12 months between endocrinologists and general practitioners improved medication for people with type 2 diabetes (T2D). Twenty-seven of 100 general practices in Aarhus, Denmark were matched and randomized. Primary outcomes: the proportion of people with T2D and 1) ischemic heart disease treated with glucagon-like peptide 1 receptor agonist (GLP1-RA) and/or sodium glucose cotransporter 2 inhibitor (SGLT2I), 2) micro/macro-albuminuria treated with angiotensin-converting-enzyme-inhibitor (ACE) or angiotensin-2-receptorantagonist (AT2), 3) low-density lipoprotein >2.5 mmol/L treated with statins. Results showed a 17.6% difference [95% CI 4.6%; 30.7%] in GLP1-RA/SGLT2I prescriptions and minimal differences for ACE/AT2 (−1.1% [95% CI −2.8%; 0.6%]) and statins (0.0% [95% CI −3.5%; 3.6%]), attributed to a ceiling effect. Video conferencing can help bridge treatment gaps, particularly for recently updated guidelines.

Abstract Image

初级和二级护理专家视频会议对2型糖尿病药物治疗的影响
尽管有希望,初级和二级护理专家之间的视频会议的临床影响缺乏试验证据。我们进行了一项两组随机对照试验(clinicaltrials.gov: NCT05268081),以评估内分泌学家和全科医生在12个月内进行的四次视频会议是否改善了2型糖尿病(T2D)患者的药物治疗。丹麦奥胡斯100个全科医生中有27个是匹配和随机的。主要结局:T2D和缺血性心脏病患者的比例:1)胰高血糖素样肽1受体激动剂(GLP1-RA)和/或葡萄糖共转运蛋白2抑制剂(SGLT2I)治疗;2)血管紧张素转换酶抑制剂(ACE)或血管紧张素2受体拮抗剂(AT2)治疗微/大量蛋白尿;3)低密度脂蛋白2.5 mmol/L他汀类药物治疗。结果显示差异为17.6% [95% CI 4.6%;30.7%]在GLP1-RA/SGLT2I处方中,ACE/AT2差异极小(- 1.1% [95% CI - 2.8%;0.6%])和他汀类药物(0.0% [95% CI−3.5%;3.6%]),归因于天花板效应。视频会议可以帮助弥合治疗差距,特别是对于最近更新的指导方针。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
25.10
自引率
3.30%
发文量
170
审稿时长
15 weeks
期刊介绍: npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics. The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信